Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Donovan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Journal of Oncology Nursing|January 31, 2013
Metastatic breast cancer epidemiology and management with a focus on taxanesDiana Donovan
Clinical Journal of Oncology Nursing|January 31, 2013
Special considerations in the management of older adult patients with metastatic breast cancerDiana Donovan
Clinical Journal of Oncology Nursing|December 2, 2009
Management of peripheral neuropathy caused by microtubule inhibitorsDiana Donovan
Cancer Management and Research|December 29, 2010
Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancerMarta Vallee Cobham, Diana Donovan
Oncology (Williston Park, N.Y.)|May 14, 2008
Epothilones: clinical update and future directionsDiana Donovan, Linda T Vahdat
Clinical Medicine Insights. Oncology|May 24, 2014
Oncology nursing support for safe and effective use of eribulin in metastatic breast cancerDiana Donovan, Laura Urquhart, Una Hopkins, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patientsGigi J Ebenezer, Karen Carlson, Diana Donovan, et al.
Breast Cancer Research and Treatment|November 29, 2007
Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancerRakhi P Naik, David Jin, Ellen Chuang, et al.
BMC Cancer|April 18, 2015
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicitySasha E Stanton, Maureen M Ward, Paul Christos, et al.
Breast Cancer Research and Treatment|December 14, 2011
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patientsSarika Jain, Maureen M Ward, Jennifer O'Loughlin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Journal of Oncology Nursing|January 31, 2013
Metastatic breast cancer epidemiology and management with a focus on taxanesDiana Donovan
Clinical Journal of Oncology Nursing|January 31, 2013
Special considerations in the management of older adult patients with metastatic breast cancerDiana Donovan
Clinical Journal of Oncology Nursing|December 2, 2009
Management of peripheral neuropathy caused by microtubule inhibitorsDiana Donovan
Cancer Management and Research|December 29, 2010
Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancerMarta Vallee Cobham, Diana Donovan
Oncology (Williston Park, N.Y.)|May 14, 2008
Epothilones: clinical update and future directionsDiana Donovan, Linda T Vahdat
Clinical Medicine Insights. Oncology|May 24, 2014
Oncology nursing support for safe and effective use of eribulin in metastatic breast cancerDiana Donovan, Laura Urquhart, Una Hopkins, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patientsGigi J Ebenezer, Karen Carlson, Diana Donovan, et al.
Breast Cancer Research and Treatment|November 29, 2007
Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancerRakhi P Naik, David Jin, Ellen Chuang, et al.
BMC Cancer|April 18, 2015
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicitySasha E Stanton, Maureen M Ward, Paul Christos, et al.
Breast Cancer Research and Treatment|December 14, 2011
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patientsSarika Jain, Maureen M Ward, Jennifer O'Loughlin, et al.
Pageof 2